| Literature DB >> 29980953 |
S Figueiredo1,2, C Taconet3,4, A Harrois3,4, S Hamada3,4, T Gauss5, M Raux6,7, J Duranteau3,4.
Abstract
BACKGROUND: The diagnostic value of hemoglobin (Hb) for detecting a significant hemorrhage (SH) in the early phase of trauma remains controversial. The present study aimed to assess the abilities of Hb measurements taken at different times throughout trauma management to identify patients with SH.Entities:
Keywords: Hemoglobin; Hemorrhage; Point-of-care systems; Resuscitation; Trauma
Year: 2018 PMID: 29980953 PMCID: PMC6035120 DOI: 10.1186/s13613-018-0420-8
Source DB: PubMed Journal: Ann Intensive Care ISSN: 2110-5820 Impact factor: 6.925
Fig. 1Flow diagram of the study
General characteristics for patients with significant hemorrhage and controls
| SH | CL | ||
|---|---|---|---|
| Age (years) | 38 [25–55] | 33[24–47] | < 0.001 |
| Male gender ( | 538 (71) | 4490 (80) | < 0.001 |
| BMI (kg cm−2) | 24 [22–27] | 24 [22–27] | NS |
| ISS | 33 [20–43] | 11 [5–20] | < 0.001 |
| Blunt ( | 656 (87) | 5020 (89) | NS |
| Time from the emergency call to the EMS arrival on trauma scene (min) | 10 [6–14] | 10 [6–15] | NS |
| Minimal systolic BPprehosp (mm Hg) | 80 [60–99] | 118 [102–130] | < 0.001 |
| Maximal HRprehosp (bpm) | 106 [80–126] | 90 [80–106] | 0.056 |
| Shock indexprehosp | 1.2 [0.8–1.5] | 0.8 [0.6–0.95] | < 0.001 |
| FVprehosp total (ml) | 1500 [1000–2000] | 500 [500–1000] | < 0.001 |
| FVprehosp crystalloids (ml) | 1000 [500–1500] | 500 [500–1000] | < 0.001 |
| FVprehosp colloids (ml) | 0 [0–500] | 0 [0–0] | < 0.001 |
| Prehospital care time (min) | 80 [60–104] | 71 [53–97] | < 0.001 |
| HR at admission (bpm) | 102 [80–120] | 86 [74–100] | < 0.001 |
| Systolic BP at admission (mm Hg) | 96 [74–117] | 129 [114–143] | < 0.001 |
| Diastolic BP at admission (mm Hg) | 76 [66–87] | 56 [42–72] | < 0.001 |
| Shock indexhosp | 1 [0.75–1.4] | 0.7 [0.6–0.8] | < 0.001 |
| Lactatehosp (mmol liter−1) | 4.3 [3–8] | 2.8 [1–3] | < 0.001 |
| Platelets (103 mm −3) | 171 [117–221] | 225 [189–264] | < 0.001 |
| Prothrombin time (quick %) | 48 [32–63] | 84 [73–93] | < 0.001 |
| Fibrinogen (g liter−1) | 1.3 [0.9–1.8] | 2.4 [2–2.8] | < 0.001 |
|
| |||
| RBCs (U) at H1 | 3 [1–4] | 0 [0–0] | < 0.001 |
| FFP (U) at H1 | 0 [0–3] | 0 [0–0] | < 0.001 |
| PLT (PC) at H1 | 0 [0–0] | 0 [0–0] | < 0.001 |
| RBCs (U) at H6 | 6 [4–8] | 0 [0–0] | < 0.001 |
| FFP (U) at H6 | 4 [3–7] | 0 [0–0] | < 0.001 |
| PLT (PC) at H6 | 0 [0–1] | 0 [0–0] | < 0.001 |
| RBCs (U) at H24 | 7 [4–10] | 0 [0–0] | < 0.001 |
| FFP (U) at H24 | 6 [3–9] | 0 [0–0] | < 0.001 |
| PLT (PC) at H24 | 1 [0–1] | 0 [0–0] | < 0.001 |
| IGS II score | 52 [37–72] | 16 [9–29] | < 0.001 |
| ICU mortality ( | 275 (37) | 364 (7) | < 0.001 |
BMI body mass index, BP arterial blood pressure, CL control, EMS emergency medical service, FFP fresh frozen plasma, FV prehospital fluid volume, H1 one hour after hospital admission, H6 six hour after trauma, H24 twenty-four hour after trauma, HR heart rate, ISS injury severity score, lactate serum lactate at the admission to hospital, NS nonsignificant, PC platelet concentrates, RBCs red blood cells, SH significant hemorrhage, shock index maximal HRprehosp/minimal systolic arterial BPprehosp, shock index HR at admission/systolic arterial BP at admission, U units
Different hemoglobin measurements and variations
| SH | CL | ||
|---|---|---|---|
| POC-Hbprehosp (g dl−1) | 12.5 [11–14] | 14.0 [13–15] | < 0.001 |
| POC-Hbhosp (g dl−1) | 9.6 [8–11] | 13.5 [12–15] | < 0.001 |
| DeltaPOC-Hb (g dl−1) | − 3 [− 5;− 1] | − 1 [− 2;0] | < 0.001 |
| Hb-Labhosp (g dl−1) | 9.3 [7.6–11] | 13.5 [12–14.5] | < 0.001 |
SH significant hemorrhage, CL controls, POC-Hb and POC-Hb prehospital and hospital hemoglobin levels provided by point-of-care device, DeltaPOC-Hb POC-Hbhosp − POC-Hbprehosp, Hb-Lab hemoglobin level provided by the laboratory at hospital admission
Predictive performances of different variables for significant hemorrhage
| Variable | AUC [IC95%] | Cutoff | Se (%) | Spe (%) | PLR (%) | NLR (%) | PPV (%) | NPV (%) | Y | Gray zone (range) |
|---|---|---|---|---|---|---|---|---|---|---|
| Shock indexprehosp | 0.71 [0.70–0.72] | 1 | 62 | 83 | 3.6 | 0.5 | 32 | 94 | 0.45 | 0.1–1.2 |
| POC-Hbprehosp (g dl−1) | 0.72 [0.71–.73] | 13 | 64 | 70 | 2.1 | 0.5 | 22 | 94 | 0.34 | 12– 15 |
| FVprehosp (ml) | 0.79 [0.78–0.80] | 900 | 78 | 68 | 2.4 | 0.3 | 25 | 96 | 0.46 | 500–1500 |
| Shock indexhosp | 0.77 [0.76–0.78] | 0.9 | 62 | 86 | 4.4 | 0.4 | 36 | 95 | 0.48 | 0.5–1 |
| POC-Hbhosp (g dl−1) | 0.88 [0.88–0.89] | 11.4 | 78 | 84 | 4.9 | 0.3 | 40 | 97 | 0.62 | 11–13 |
| DeltaPOC-Hb (g dl−1) | 0.77 [0.76–0.78] | − 2 | 70 | 77 | 3.0 | 0.4 | 29 | 95 | 0.46 | − 3–0 |
| Lactatehosp (mmol liter−1) | 0.81 [0.80–0.83] | 3.5 | 63 | 87 | 4.7 | 0.4 | 41 | 94 | 0.49 | 2–4 |
| Hb-Labhosp (g dl−1) | 0.92 [0.91–0.92] | 11.8 | 88 | 81 | 4.5 | 0.2 | 37 | 98 | 0.68 | 11–12 |
Shock indexprehosp = maximal HRprehosp/minimal systolic arterial BPprehosp; POC-Hbprehosp prehospital hemoglobin level provided by the point-of-care HemoCue® device; FVprehosp prehospital fluid volume infused; POC-Hbhosp hemoglobin level provided by the point-of-care HemoCue® device at hospital admission; DeltaPOC-Hb = POC-Hbhosp - POC-Hbprehosp; Hb-Labhosp hemoglobin level provided by the laboratory at hospital admission; shock indexhosp = HR at admission/systolic arterial BP at admission
AUC area under the ROC curve, Se sensitivity, Spe specificity, PLR positive likelihood ratio, NLR negative likelihood ratio, POC point-of-care, PPV positive predictive value, NPV negative predictive value, Y Youden
Fig. 2Receiver operating characteristic (ROC) curves describing the abilities of different parameters to predict significant hemorrhage. Hb-Lab hemoglobin level provided by the laboratory at hospital admission, POC-Hb and POC-Hb prehospital and hospital hemoglobin levels provided by the point-of-care (POC) HemoCue® device, DeltaPOC-Hb POC-Hbhosp − POC-Hbprehosp, FV prehospital fluid volume infused, lactate serum lactate measured at hospital admission
Fig. 3Relationship between the Hb drop from prehospital phase to hospital admission measured by POC device (DeltaPOC-Hb = POC-Hbhosp − POC-Hbprehosp) and the prehospital fluid volume (FVprehosp) infused according to the level of bleeding (LB): significant hemorrhage (SH) or controls (CL). Multivariate linear regression without interaction term: Multivariate linear regression with interaction term: For the same prehospital fluid volume infused, the Hb drop from prehospital phase to hospital admission measured by POC device (DeltaPOC-Hb) was larger in patients with SH than in CL